Illness trajectories of incurable solid cancers
- PMID: 38428972
- PMCID: PMC10905388
- DOI: 10.1136/bmj-2023-076625
Illness trajectories of incurable solid cancers
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare that they have no competing interests.
Figures
Comment in
-
Illness trajectories in the age of big data.BMJ. 2024 Mar 1;384:q510. doi: 10.1136/bmj.q510. BMJ. 2024. PMID: 38428967 No abstract available.
-
Is there too much care in advanced cancer?BMJ. 2024 Apr 5;385:q784. doi: 10.1136/bmj.q784. BMJ. 2024. PMID: 38580383 No abstract available.
References
-
- GBD 2017 Causes of Death Collaborators . Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1736-88. 10.1016/S0140-6736(18)32203-7. - DOI - PMC - PubMed
-
- National Cancer Institute. Cancer statistics. 2020. https://www.cancer.gov/about-cancer/understanding/statistics.
-
- Nabholtz JM, Buzdar A, Pollak M, et al. Arimidex Study Group . Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. J Clin Oncol 2000;18:3758-67. 10.1200/JCO.2000.18.22.3758. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical